The first pacemaker manufacturer in China.
The highest clinical application rate of cardiac occluder in China.
The largest R&D manufacturer of mechanical heart valves in Asia.
Why Choose Us
;
Artificial intelligence "cardiogram analysis software"
The first domestic model to be approved for registration, currently the only one that has been approved by NMPA at the same time
FDA approved and CE certified artificial intelligence ECG products.
—— Passed the US FDA registration and approval
on November 19, 2018
—— Obtained the EU CE certificate on November 5, 2018
—— Obtained NMPA registration approval on January 22, 2020
AI-ECG Intellectual Property
—— 13 patents have passed the preliminary examination and 9 patents are under application;
—— 14 trademarks have passed the preliminary examination and 35 trademarks are in the process of application.